Partnered implementation of the veteran sponsorship initiative: protocol for a randomized hybrid type 2 effectiveness-implementation trial.
Partnered implementation of the veteran sponsorship initiative: protocol for a randomized hybrid type 2 effectiveness-implementation trial.
复制标题
DOI：
10.1186/s13012-022-01212-9
复制
发表时间：
2022-07-08
影响因子：
7.2
通讯作者：
Goodman, Marianne
中科院分区：
文献类型：
--
作者：
Geraci, Joseph C.;Finley, Erin P.;Edwards, Emily R.;Frankfurt, Sheila;Kurz, A. Solomon;Kamdar, Nipa;Vanneman, Megan E.;Lopoo, Leonard M.;Patnaik, Hannah;Yoon, Jean;Armstrong, Nicholas;Greene, Ashley L.;Cantor, Gilly;Wrobleski, Joseph;Young, Erin;Goldsmith, Matthew;Seim, Richard W.;Goodman, Marianne
关键词：
美国最年轻的退伍军人（18至34岁）正在经历一场自杀流行病，自2001年以来，他们的自杀率几乎翻了一番。退伍军人在退伍后的第一年面临的风险最高，因此造成了“致命的差距”。作为回应，国家制定了战略，强调预防性、普遍性和公共卫生方法，并接受社区干预的价值。自杀的三步理论表明，减少重返社会困难和促进退伍军人在过渡到平民生活时的联系的社区干预措施最有可能减少自杀。最近的研究表明，社区干预措施的有效性可以得到加强时，由志愿者和认证的赞助商（1对1）谁积极参与退伍军人，作为退伍军人赞助计划（VSI）的一部分。这项随机混合2型有效性实施试验的目的是与美国国防部、劳工部和退伍军人事务部、德克萨斯州政府以及当地利益相关者合作，评估VSI在德克萨斯州六个城市的实施情况。德克萨斯州是这一大规模实施的最佳地点，因为它拥有这些年轻退伍军人的第二大人口，并且是美国最大的军事设施胡德堡的所在地。第一个目的是确定VSI的有效性，通过重新融合困难、健康/心理困扰、VA医疗保健利用、连通性和自杀风险的测量来证明。第二个目标是确定在德克萨斯州实施VSI的业主参与计划的可行性和潜在效用，以便将来在更多的州扩展。评估人员将采用阶梯式楔形设计，并随着时间的推移逐步向参与城市推广。参与者（n=630）将在退伍前六个月在军事设施登记。执行工作将利用一揽子执行战略，其中包括持续培训、执行便利以及审计和反馈等战略。形成性和总结性评价将以“覆盖、有效性、采用、实施和维护”（RE-AIM）框架为指导，并将包括与参与者的访谈和与关键利益攸关方的定期反思，以纵向确定实施的障碍和促进因素。这项评估将对国家实施社区干预措施以解决退伍军人自杀流行病产生重要影响。根据《证据法》，这是第一次大规模实施循证实践，在“致命差距”期间对TSMV进行彻底评估。ClinicalTrials.gov ID号：NCT 05224440。于2022年2月4日注册。在线版本包含补充材料，可通过10.1186/s13012-022-01212-9获得。
The USA is undergoing a suicide epidemic for its youngest Veterans (18-to-34-years-old) as their suicide rate has almost doubled since 2001. Veterans are at the highest risk during their first-year post-discharge, thus creating a “deadly gap.” In response, the nation has developed strategies that emphasize a preventive, universal, and public health approach and embrace the value of community interventions. The three-step theory of suicide suggests that community interventions that reduce reintegration difficulties and promote connectedness for Veterans as they transition to civilian life have the greatest likelihood of reducing suicide. Recent research shows that the effectiveness of community interventions can be enhanced when augmented by volunteer and certified sponsors (1-on-1) who actively engage with Veterans, as part of the Veteran Sponsorship Initiative (VSI). The purpose of this randomized hybrid type 2 effectiveness-implementation trial is to evaluate the implementation of the VSI in six cities in Texas in collaboration with the US Departments of Defense, Labor and Veterans Affairs, Texas government, and local stakeholders. Texas is an optimal location for this large-scale implementation as it has the second largest population of these young Veterans and is home to the largest US military installation, Fort Hood. The first aim is to determine the effectiveness of the VSI, as evidenced by measures of reintegration difficulties, health/psychological distress, VA healthcare utilization, connectedness, and suicidal risk. The second aim is to determine the feasibility and potential utility of a stakeholder-engaged plan for implementing the VSI in Texas with the intent of future expansion in more states. The evaluators will use a stepped wedge design with a sequential roll-out to participating cities over time. Participants (n=630) will be enrolled on military installations six months prior to discharge. Implementation efforts will draw upon a bundled implementation strategy that includes strategies such as ongoing training, implementation facilitation, and audit and feedback. Formative and summative evaluations will be guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework and will include interviews with participants and periodic reflections with key stakeholders to longitudinally identify barriers and facilitators to implementation. This evaluation will have important implications for the national implementation of community interventions that address the epidemic of Veteran suicide. Aligned with the Evidence Act, it is the first large-scale implementation of an evidence-based practice that conducts a thorough assessment of TSMVs during the “deadly gap.” ClinicalTrials.gov ID number: NCT05224440. Registered on 04 February 2022. The online version contains supplementary material available at 10.1186/s13012-022-01212-9.
登录
查看更多内容
影响因子：
2.2
作者：
Cleveland EC;Azrael D;Simonetti JA;Miller M
通讯作者：
Miller M
影响因子：
4.4
作者：
Booth-Kewley S;Schmied EA;Highfill-McRoy RM;Larson GE;Garland CF;Ziajko LA
通讯作者：
Ziajko LA
影响因子：
5.2
作者：
Belfield, CR;Nores, M;Schweinhart, L
通讯作者：
Schweinhart, L
影响因子：
3.8
作者：
Geraci, Joseph C.;Mobbs, Meaghan;Goodman, Marianne
通讯作者：
Goodman, Marianne
影响因子：
--
作者：
Bush, K;Kivlahan, DR;Bradley, KA
通讯作者：
Bradley, KA